Galitzky J - Search Results

1

Endothelial DLL4 Is an Adipose Depot-Specific Fasting Sensor Regulating Fatty Acid Fluxes.

Aupetit A, Decaunes P, Belles C, Riant E, Galitzky J, Chapouly C, Laisné M, Flores-Flores R, Chaput B, Vié K, Arnal JF, Bouloumié A, Briot A. Aupetit A, et al. Among authors: galitzky j. Arterioscler Thromb Vasc Biol. 2023 May;43(5):684-696. doi: 10.1161/ATVBAHA.122.318876. Epub 2023 Mar 16. Arterioscler Thromb Vasc Biol. 2023. PMID: 36924232 Free article.

2

Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase.

Bousquet-Mélou A, Galitzky J, Moreno CM, Berlan M, Lafontan M. Bousquet-Mélou A, et al. Among authors: galitzky j. Eur J Pharmacol. 1995 Apr 28;289(2):235-47. doi: 10.1016/0922-4106(95)90100-0. Eur J Pharmacol. 1995. PMID: 7621897

3

Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.

Paris H, Galitzky J, Senard JM. Paris H, et al. Among authors: galitzky j. Mol Pharmacol. 1989 Mar;35(3):345-54. Mol Pharmacol. 1989. PMID: 2564632

4

Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.

Berlan M, Galitzky J, Riviere D, Foureau M, Tran MA, Flores R, Louvet JP, Houin G, Lafontan M. Berlan M, et al. Among authors: galitzky j. Int J Obes. 1991 May;15(5):305-15. Int J Obes. 1991. PMID: 1885256

5

Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences.

Mauriege P, Galitzky J, Berlan M, Lafontan M. Mauriege P, et al. Among authors: galitzky j. Eur J Clin Invest. 1987 Apr;17(2):156-65. doi: 10.1111/j.1365-2362.1987.tb02395.x. Eur J Clin Invest. 1987. PMID: 3034620

6

Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.

Carpéné C, Galitzky J, Larrouy D, Langin D, Lafontan M. Carpéné C, et al. Among authors: galitzky j. Biochem Pharmacol. 1990 Aug 1;40(3):437-45. doi: 10.1016/0006-2952(90)90541-r. Biochem Pharmacol. 1990. PMID: 1974423

7

Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.

Galitzky J, Senard JM, Lafontan M, Stillings M, Montastruc JL, Berlan M. Galitzky J, et al. Br J Pharmacol. 1990 Aug;100(4):862-6. doi: 10.1111/j.1476-5381.1990.tb14105.x. Br J Pharmacol. 1990. PMID: 1976403 Free PMC article.

8

Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.

Galitzky J, Rivière D, Tran MA, Montastruc JL, Berlan M. Galitzky J, et al. Eur J Clin Pharmacol. 1990;39(5):447-51. doi: 10.1007/BF00280934. Eur J Clin Pharmacol. 1990. PMID: 1963844

9

Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.

Galitzky J, Taouis M, Berlan M, Rivière D, Garrigues M, Lafontan M. Galitzky J, et al. Eur J Clin Invest. 1988 Dec;18(6):587-94. doi: 10.1111/j.1365-2362.1988.tb01272.x. Eur J Clin Invest. 1988. PMID: 2906290 Clinical Trial.

10

Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.

Berlan M, Galitzky J, Bousquet-Melou A, Lafontan M, Montastruc JL. Berlan M, et al. Among authors: galitzky j. J Pharmacol Exp Ther. 1994 Mar;268(3):1444-51. J Pharmacol Exp Ther. 1994. PMID: 7908057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters